Kathryn Ballard
Family · Blacksburg, VANPI 1467139782
Payments from drug & device makers
Across 117 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$324
- AbbVie$255
- Lilly USA, LLC$180
- Pfizer$175
- Amgen$158
- Xeris Pharmaceuticals, Inc.$100
- plus $723 from 16 others
What the payments were for
- Food & beverage$1,916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $324 |
| AbbVie | 15 | $255 |
| Lilly USA, LLC | 10 | $180 |
| Pfizer | 15 | $175 |
| Amgen | 10 | $158 |
| Xeris Pharmaceuticals, Inc. | 5 | $100 |
| Boehringer Ingelheim | 4 | $99 |
| Bayer | 5 | $79 |
| Astellas Pharma US Inc | 4 | $67 |
| Novartis | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| AstraZeneca | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Dexcom, Inc. | 1 | $36 |
| Lundbeck LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Corium, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| GSK | 1 | $15 |
How this compares
$1,916 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 96 | $143,590 |
| JardianceEmpagliflozin | 90 | $82,850 |
| EliquisApixaban | 33 | $29,064 |
| TrulicityDulaglutide | 18 | $23,357 |
| JanuviaSitagliptin Phosphate | 23 | $20,852 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $19,069 |
| MyrbetriqMirabegron | 23 | $14,570 |
| MounjaroTirzepatide | 12 | $13,412 |
| InvokanaCanagliflozin | 14 | $11,358 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $7,273 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $6,986 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $6,945 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $5,454 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $4,957 |
| Insulin Degludec Pen (U-200)Insulin Degludec | 14 | $4,808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $324 | $143,59096 claims |
| Boehringer IngelheimJardiance | $99 | $82,85090 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $180 | $36,76930 claims |
| PfizerEliquis | $175 | $29,06433 claims |
| Astellas Pharma US IncMyrbetriq | $67 | $14,57023 claims |
| AstraZenecaSymbicort | $44 | $7,27326 claims |
| AbbVieSynthroid | $255 | $1,12621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,332 family providers in Virginia.
Other family in Blacksburg
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.